Market Value635,740,442
Total Holdings68
File Date2026-02-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CELC / Celcuity Inc.
NMTC / NeuroOne Medical Technologies Corporation
AVTX / Avalo Therapeutics, Inc.
PRQR / ProQR Therapeutics N.V.
EWTX / Edgewise Therapeutics, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
ALKS / Alkermes plc
BTSG / BrightSpring Health Services, Inc.
CRL / Charles River Laboratories International, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
FULC / Fulcrum Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
KVUE / Kenvue Inc.
MCK / McKesson Corporation
NXTC / NextCure, Inc.
NYXH / Nyxoah SA
RYTM / Rhythm Pharmaceuticals, Inc. Put
VTYX / Ventyx Biosciences, Inc.
XLO / Xilio Therapeutics, Inc.
MRK / Merck & Co., Inc.
HSIC / Henry Schein, Inc.
KALV / KalVista Pharmaceuticals, Inc.
NVCR / NovoCure Limited
SENS / Senseonics Holdings, Inc.
APRE / Aprea Therapeutics, Inc.
SEPN / Septerna, Inc.
OTLK / Outlook Therapeutics, Inc. Put
GSK / GSK plc - Depositary Receipt (Common Stock)
TFX / Teleflex Incorporated
DNTH / Dianthus Therapeutics, Inc.
CNTX / Context Therapeutics Inc.
FHTX / Foghorn Therapeutics Inc.
ENTA / Enanta Pharmaceuticals, Inc.
BMRN / BioMarin Pharmaceutical Inc.
SLP / Simulations Plus, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
COR / Cencora, Inc.
CCRN / Cross Country Healthcare, Inc.
OGN / Organon & Co.
CNC / Centene Corporation
SENS / Senseonics Holdings, Inc.
PMVP / PMV Pharmaceuticals, Inc.
ALGS / Aligos Therapeutics, Inc.
ANIP / ANI Pharmaceuticals, Inc.
BBOT / BridgeBio Oncology Therapeutics, Inc.
VIR / Vir Biotechnology, Inc.
MMS / Maximus, Inc.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
KYMR / Kymera Therapeutics, Inc.
TARA / Protara Therapeutics, Inc.
SI / Shoulder Innovations, Inc.
ICLR / ICON Public Limited Company
RAPP / Rapport Therapeutics, Inc.
HYPR / Hyperfine, Inc.
WAY / Waystar Holding Corp.
DRUG / Bright Minds Biosciences Inc.
HUMAW / Humacyte, Inc. - Equity Warrant
TYRA / Tyra Biosciences, Inc.
IBIO / iBio, Inc.
ERAS / Erasca, Inc.
TERN / Terns Pharmaceuticals, Inc.
BOLD / Boundless Bio, Inc.
AQST / Aquestive Therapeutics, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
TELA / TELA Bio, Inc.
LIVN / LivaNova PLC
SVRA / Savara Inc.
ORKA / Oruka Therapeutics, Inc.
ADGM / Adagio Medical Holdings, Inc.
AVR / Anteris Technologies Global Corp.
OVID / Ovid Therapeutics Inc.
CI / The Cigna Group
BHVN / Biohaven Ltd.
ZBH / Zimmer Biomet Holdings, Inc.
ELTX / Elicio Therapeutics, Inc. Put
IRON / Disc Medicine, Inc.
HAE / Haemonetics Corporation
MODD / Modular Medical, Inc.